Tfo Tdc, LLC Harmony Biosciences Holdings, Inc. Transaction History

Tfo Tdc, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$29.93 - $35.06 $29,540 - $34,604	-987 Reduced 99.9%	1 $0
Q4 2023 Feb 12, 2024	BUY	$19.2 - $33.78 $18,950 - $33,340	987 Added 98700.0%	988 $31,000
Q1 2023 May 03, 2023	SELL	$30.8 - $53.92 $800 - $1,401	-26 Reduced 96.3%	1 $0
Q4 2022 Feb 03, 2023	BUY	$45.4 - $60.91 $1,225 - $1,644	27 New	27 $1,000

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.